long covid

  1. E

    Polybio Fall 2023 Symposium

    Polybio Fall 2023 Symposium "Join us online Friday Oct. 20 for updates on PolyBio supported projects & collaborations including those spearheaded by the #LongCovid Research Consortium. " Register on Zoom:https://us02web.zoom.us/webinar/register/WN__cnUbsaISb-D0AtXQ9yGbQ#/registration Speakers...
  2. ahimsa

    Professor Akiko Iwasaki and the Yale School of Medicine research on Long Covid and post infection syndromes

    The Latest on Long Covid Research with Dr. Iwasaki Hosted by Body Politic Mon, April 4, 2022 3:00 PM – 4:00 PM Pacific / 6:00 PM - 7:00 PM Eastern Register here - https://www.eventbrite.com/e/the-latest-on-long-covid-research-with-dr-iwasaki-tickets-308247335077 Or watch free on the Body...
  3. SNT Gatchaman

    Structural and functional impairments of skeletal muscle in patients with [PASC], 2023, Colosio et al.

    Structural and functional impairments of skeletal muscle in patients with post-acute sequelae of SARS-CoV-2 infection Marta Colosio ; Lorenza Brocca ; Marco Gatti ; Marianna Neri ; Emanuela Crea ; Francesca Cadile ; Monica Canepari ; Maria Antonietta Pellegrino ; Biagio Polla ; Simone...
  4. Hoopoe

    What can I do to treat covid-19 infection?

    I think I have covid. I am not sure that I'm up to date on what should be done in this situation. Please advise. Symptoms started 3 days ago with a sore throat. Now a stuffy nose, cough with a little production of phlegm, and a bit of malaise. No worrying symptoms but I'm a little concerned...
  5. E

    Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases, 2023,

    Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases Editor’s summary It is not clear why some individuals develop postacute sequelae of COVID-19 (PASC) while others do not. Here, Herman et al. used systems serology...
  6. SNT Gatchaman

    COVID-19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain, 2023, Roczkowsky et al.

    COVID-19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain A. Roczkowsky; D. Limonta; J. P. Fernandes; W. G. Branton; M. Clarke; B. Hlavay; R. S. Noyce; J. T. Joseph; N. S. Ogando; S. K. Das; M. Elaish; N. Arbour; D. H. Evans; K. Langdon; T. C. Hobman; C. Power Objective...
  7. E

    Review SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC), 2023, Proal et al

    SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Abstract Millions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC). Several biological factors have emerged as potential drivers of PASC pathology. Some individuals with PASC may not fully clear the...
  8. Midnattsol

    Open EhEx-COV19, Trondheim, Norway

    (Google translated from the study website) Training after undergoing corona disease Are you struggling to get started with physical activity after having covid-19? Now you can help us find out whether a new e-Health tool is an effective aid in training after corona. Who can participate? You...
  9. E

    Preprint SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide,

    SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide Abstract An increasing number of reports suggest an association between COVID-19 infection and initiation or acceleration of neurodegenerative...
  10. SNT Gatchaman

    Trial Report The Long-COVID autonomic syndrome in hospitalized patients: A one-year prospective cohort study, 2023, Rigo et al.

    The Long-COVID autonomic syndrome in hospitalized patients: A one-year prospective cohort study Stefano Rigo; Franca Barbic; Kareem Khalaf; Andrea Bisoglio; Margherita Pani; Maura Minonzio; Luca Rinaldi; Michele Ciccarelli; Maria Grazia Bordoni; Paolo Verzeletti; Fabio Badilini; Stefanos...
  11. E

    Haunting innate immune memories of COVID-19, 2023, Birgit Sawitzki

    Haunting innate immune memories of COVID-19 In addition to acute hyperinflammatory responses, SARS-CoV-2 infections can have long-term effects on our immune system leading to, for example, post-acute sequelae of COVID-19 (PASC). In this issue of Cell, Cheong et al. show that severe infections...
  12. E

    Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization, 2023, Taquet et al

    Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization Abstract Post-COVID cognitive deficits, including ‘brain fog’, are clinically complex, with both objective and subjective components. They are common and debilitating, and can affect the...
  13. E

    Preprint SARS-CoV-2 RNA Persists in the Central Nervous System of Non-Human Primates Despite Clinical Recovery, 2023, Booze et al

    SARS-CoV-2 RNA Persists in the Central Nervous System of Non-Human Primates Despite Clinical Recovery Abstract Adverse neurological and psychiatric outcomes, collectively termed the post-acute sequelae of SARS-CoV-2 infection (PASC), persist in adults clinically recovered from COVID-19...
  14. SNT Gatchaman

    Characteristics and Treatment of Exercise Intolerance in Patients With Long COVID, 2023, Edward et al

    Characteristics and Treatment of Exercise Intolerance in Patients With Long COVID Edward, Justin A.;Peruri, Adithya;Rudofker, Eric;Shamapant, Nikhil;Parker, Hugh;Cotter, Ryan;Sabin, Katherine;Lawley, Justin;Cornwell, William K. III The post-acute sequalae of SARS-CoV-2, also known as “Long...
  15. E

    Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study, 2023, Congdon et al

    Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study We conducted a retrospective cohort study to assess whether treatment with nirmatrelvir/ritonavir was associated with a reduced risk of long COVID. We enrolled 500 adults with confirmed SARS-CoV-2 who were...
  16. Kalliope

    Long-term symptom severity and clinical biomarkers in post-COVID-19/[CFS]: results from a prospective observational cohort, 2023, Legler+

    eClinicalMedicine Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome:results from a prospective observational cohort Legler et al Summary Background Post-COVID-19 syndrome (PCS) is characterised by a wide range of symptoms, primarily fatigue and...
  17. E

    Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model 2023 Turner et al

    A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model HIGHLIGTS Imaging flow cytometry utilizing a novel rapid flow cytometric detection method is a promising method for detecting amyloid fibrin(ogen) microclots in conditions associated with...
  18. E

    Muscle abnormalities worsen after post-exertional malaise in long COVID, 2023/4, Wüst, van Vugt, Appelman et al

    Muscle Abnormalities Contribute to Post-Exertional Malaise in Long COVID A poster presentation of the very soon to be published work by Rob Wüsts team has been uploaded to Twitter. Paper now published, see post #8
  19. Wyva

    Gray Matter Changes Following Mild COVID-19: An MR Morphometric Study in Healthy Young People, 2023, Janszky et al

    Abstract Background Although COVID-19 is primarily an acute respiratory infection, 5%–40% of patients develop late and prolonged symptoms with frequent neurological complaints, known as long COVID syndrome. The presentation of the disease suggests that COVID infection may cause functional...
  20. E

    Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2

    Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2 Highlights Persistence of SARS-CoV-2 infection among immunocompromised patients are due to inability of the immune system to eliminate the virus...
Back
Top Bottom